trial.
9. There are insufﬁcient data to recommend transfemoral CAS as primary therapy for neurologically
asymptomatic patients with 70% to 99% diameter
stenosis. Data from CREST, ACT, and the VQI suggest
that in properly selected asymptomatic patients,
CAS may be equivalent to CEA in the hands of experienced interventionalists. Operators and institutions
performing CAS must exhibit expertise sufﬁcient to
meet the